Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Biodefense and Pandemic Vaccine and Drug Development Act of 2006
Client: CANGENE CORPORATION · Firm: CANGENE CORPORATION
HR 5533, S 2564, and S 3678, BioShield II legislation. Monitor legislation regarding biodefense vaccines and therapeutics, and preparation for possible pandemic. Discuss possible changes to provisions of S 2564 and S 3678 to address procurement concerns.
Pandemic and All-Hazards Preparedness Act
Client: CANGENE CORPORATION · Firm: CANGENE CORPORATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CANGENE CORPORATION via CANGENE CORPORATION
2007 · year_end · YY
Monitor legislation regarding biodefense vaccines, biodefense therapeutics, and pandemic preparedness.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
CANGENE CORPORATION via CANGENE CORPORATION
2007 · mid_year · MM
Source: Senate LDA
HR 5533, S 2564, and S 3678, BioShield II legislation. Monitor legislation regarding biodefense vaccines and therapeutics, and preparation for possible pandemic. Discuss possible changes to provisions of S 2564 and S 3678 to address procurement concerns.
Department of Veterans Affairs Claims Backlog Reduction Act of 2002
Client: CANGENE CORPORATION · Firm: CANGENE CORPORATION
HR 5533, S 2564, and S 3678, BioShield II legislation. Monitor legislation regarding biodefense vaccines and therapeutics, and preparation for possible pandemic. Discuss possible changes to provisions of S 2564 and S 3678 to address procurement concerns.
Monitor legislation regarding biodefense vaccines, biodefense therapeutics, and pandemic preparedness. Discuss possible legislation addressing procurement processes for Project BioShield and legislation addressing the Biologics Price Competition and Innovation Act of 2007.
Filing targets: Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
CANGENE CORPORATION via CANGENE CORPORATION
2006 · year_end · YY
HR 5533, S 2564, and S 3678, BioShield II legislation. Monitor legislation regarding biodefense vaccines and therapeutics, and preparation for possible pandemic. Discuss possible changes to provisions of S 2564 and S 3678 to address procurement concerns.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE